AKEBIA THERAPEUTICS, INC. (AKBA) Net margin 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) net profit margin by fiscal year — reported net income divided by reported revenue.
-2.2%FY2025 · since FY2016: -8843.5% → -2.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2.2% | +41.1 pp |
| FY2024 | -43.3% | -16.7 pp |
| FY2023 | -26.7% | +5.5 pp |
| FY2022 | -32.2% | +101.0 pp |
| FY2021 | -133.2% | -2.6 pp |
| FY2020 | -130.6% | -47.1 pp |
| FY2019 | -83.5% | -14.4 pp |
| FY2018 | -69.1% | -28.5 pp |
| FY2017 | -40.7% | +8802.8 pp |
| FY2016 | -8843.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice